Our findings indicate that deletion of TAK1 in fibroblasts improves cardiac structural and functional remodeling after MI, which is associated with diminished post-MI abundance of immune cells and lower levels of resident macrophages. The gene discussed is MAP3K7; the disease is myocardial infarction.